CDC: Methicillin-resistant Staphylococcus aureus: United States. MMWR. 1981, 30: 557-559.
Google Scholar
CDC: Four pediatric deaths from community-acquired methicillin resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR. 1999, 48: 707-710.
Google Scholar
Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide experience. Emerg Infect Dis. 2003, 9: 978-984.
Article
PubMed
PubMed Central
Google Scholar
Ellington MJ, Perry C, Ganner M, Warner M, McCormick Smith I, Hill RL, Shallcross L, Sabersheikh S, Holmes A, Cookson BD, Kearns AM: Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis. 2009, 28: 1113-1121. 10.1007/s10096-009-0757-x.
Article
CAS
PubMed
Google Scholar
Antri K, Rouzic N, Dauwalder O, Boubekri I, Bes M, Lina G, Vandenesch F, Tazir M, Ramdani-Bouguessa N, Etienne J: High prevalence of methicillin-resistant Staphylococcus aureusclone ST80-IV in hospital and community settings in Algiers. Clin Microbiol Infect. 2010,
Google Scholar
Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H: Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002, 35: 819-824. 10.1086/342576.
Article
CAS
PubMed
Google Scholar
Bocchini CE, Hulten KG, Mason EO, Gonzalez BE, Hammerman WA, Kaplan SL: Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006, 117: 433-440. 10.1542/peds.2005-0566.
Article
PubMed
Google Scholar
Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL: Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003, 22: 593-598. 10.1097/00006454-200307000-00006.
PubMed
Google Scholar
Hyun DY, Mason EO, Forbes A, Kaplan SL: Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2009, 28: 57-59. 10.1097/INF.0b013e3181826e5e.
Article
PubMed
Google Scholar
Mongkolrattanothai K, Aldag JC, Mankin P, Gray BM: Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois. BMC Infect Dis. 2009, 9: 112-10.1186/1471-2334-9-112.
Article
PubMed
PubMed Central
Google Scholar
Aires de Sousa M, Bartzavali C, Spiliopoulou I, Santos Sanches I, Crisóstomo MI, de Lencastre H: Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J Clin Microbiol. 2003, 41: 2027-2032. 10.1128/JCM.41.5.2027-2032.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I: Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect. 2006, 12: 29-34. 10.1111/j.1469-0691.2005.01295.x.
Article
CAS
PubMed
Google Scholar
Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French GL, Lewis D, British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections: Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother. 2008, 61: 976-994. 10.1093/jac/dkn096.
Article
CAS
PubMed
Google Scholar
Clinical and Laboratory Standards Institute, CLSI: M02-A10. Performance standards for antimicrobial disk susceptibility tests; tenth edition. 2009, CLSI: Wayne PA-USA
Google Scholar
Clinical and Laboratory Standards Institute, CLSI: M100-S20. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. 2009, CLSI: Wayne PA-USA
Google Scholar
The European Committee on Antimicrobial Susceptibility Testing (EUCAST): Breakpoint tables for interpretations of MICs and zone diameters. Version 1.1, April 2010. [http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.1.pdf]
Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000, 38: 1008-1015.
CAS
PubMed
PubMed Central
Google Scholar
Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, Reverdy ME, Enright MC, Vandenesch F, Etienne J: Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007, 13: 594-600. 10.3201/eid1304.061316.
Article
CAS
PubMed
PubMed Central
Google Scholar
Otter JA, French GL: Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis. 2010, 10: 227-239. 10.1016/S1473-3099(10)70053-0.
Article
PubMed
Google Scholar
Ben Nejma M, Mastouri M, Bel Hadj Jrad B, Nour M: Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureusclone in Tunisia. Diagn Microbiol Infect Dis. 2008,
Google Scholar
Adler A, Givon-Lavi N, Moses AE, Block C, Dagan R: Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in Southern Israel: risk factors and molecular features. J Clin Microbiol. 2010, 48: 531-538. 10.1128/JCM.02290-08.
Article
CAS
PubMed
Google Scholar
Crémieux AC, Dumitrescu O, Lina G, Vallee C, Côté JF, Muffat-Joly M, Lilin T, Etienne J, Vandenesch F, Saleh-Mghir A: Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009, 4: e7204-10.1371/journal.pone.0007204.
Article
PubMed
PubMed Central
Google Scholar
Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M: Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007, 13: 1510-1514. 10.1038/nm1656.
Article
CAS
PubMed
Google Scholar
Kaplan SL, Hulten KG, Hammerman WA, Lamberth L, Versalovic J, Mason EO: Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005, 40: 1785-1791. 10.1086/430312.
Article
PubMed
Google Scholar
Fortunov RM, Hulten KG, Hammerman WA, Mason EO, Kaplan SL: Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006, 118: 874-881. 10.1542/peds.2006-0884.
Article
PubMed
Google Scholar
O'Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I: Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol. 2007, 45: 1505-1510. 10.1128/JCM.01984-06.
Article
PubMed
PubMed Central
Google Scholar
O'Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I: Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother. 2007, 51: 1737-1740. 10.1128/AAC.01542-06.
Article
PubMed
PubMed Central
Google Scholar
Lannergård J, Norström T, Hughes D: Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2009, 53: 2059-2065. 10.1128/AAC.00871-08.
Article
PubMed
PubMed Central
Google Scholar
Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J: Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis. 2002, 8: 602-607.
Article
PubMed
PubMed Central
Google Scholar
Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, Glupczynski Y, Malaviolle X, Vergison A, Struelens MJ: Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother. 2005, 56: 1103-1106. 10.1093/jac/dki379.
Article
CAS
PubMed
Google Scholar
Wannet W, Spalburg E, Heck ME, Pluister GN, Tiemersma E, Willems RJ, Huijsdens XW, de Neeling AJ, Etienne J: Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands. J Clin Microbiol. 2005, 43: 3341-3345. 10.1128/JCM.43.7.3341-3345.2005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Witte W, Braulke C, Cuny C, Strommenger B, Werner G, Heuck D, Jappe U, Wendt C, Linde H-J, Harmsen D: Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis. 2005, 24: 1-5. 10.1007/s10096-004-1262-x.
Article
CAS
PubMed
Google Scholar
Comité de l' Antibiogramme de la Société Française de Microbiologie: Recommandations 2008 (Edition de Janvier 2008). [http://www.sfm.asso.fr/doc/download.php?doc=DiU8C&fic=casfm_2008.pdf]
Jones RN, Castanheira M, Rhomberg PR, Woosley LN, Pfaller MA: Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus. J Clin Microbiol. 2010, 48: 972-976. 10.1128/JCM.01829-09.
Article
CAS
PubMed
PubMed Central
Google Scholar
Livermore D, James D, Duckworth G, Stephens P: Fusidic-acid use and resistance. Lancet. 2002, 360: 806-10.1016/S0140-6736(02)09921-X.
Article
PubMed
Google Scholar
Howden BP, Grayson ML: Dumb and dumber-The potential waste of a useful antistaphylococcal agent: Emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis. 2006, 42: 394-400. 10.1086/499365.
Article
CAS
PubMed
Google Scholar
Kaplan SL: Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. 2006, 17: 113-119. 10.1053/j.spid.2006.06.004.
Article
PubMed
Google Scholar
Stevens DL, Ma Y, Salmi D, McIndoo E, Wallace RJ, Bryant AE: Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007, 195: 202-211. 10.1086/510396.
Article
CAS
PubMed
Google Scholar
Siberry GK, Tekle T, Carroll K, Dick J: Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003, 37: 1257-1260. 10.1086/377501.
Article
PubMed
Google Scholar
Daurel C, Huet C, Dhalluin A, Bes M, Etienne J, Leclercq R: Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J Clin Microbiol. 2008, 46: 546-550. 10.1128/JCM.01925-07.
Article
CAS
PubMed
Google Scholar
Fergie J, Purcell K: The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2008, 27: 67-68. 10.1097/INF.0b013e31816087a7.
Article
PubMed
Google Scholar
Hyun DY, Mason EO, Forbes A, Kaplan SL : Trimethoprim-sulfamethoxasole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2008, 28: 57-59.
Article
Google Scholar
Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH, Hardy RD: Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis. 2004, 23: 123-127. 10.1097/01.inf.0000109288.06912.21.
Article
Google Scholar
Duong M, Markwell S, Peter J, Barenkamp S: Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010, 55: 401-407. 10.1016/j.annemergmed.2009.03.014.
Article
PubMed
Google Scholar